CLAIRE TIGLAO: Open Payments
NPI 1205289469 · PANAMA CITY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 13 payments from 7 companies in 2025. Trend: 2023 $886 · 2024 $613 · 2025 $796
Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $207 |
| Vanda Pharmaceuticals Inc. | 4 | $177 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| MDD US Operations, LLC | 1 | $118 |
| Otsuka America Pharmaceutical, Inc. | 1 | $113 |
| Supernus Pharmaceuticals, Inc. | 3 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
Products named: Auvelity, FANAPT, Qelbree, CAPLYTA, REXULTI, COBENFY.
Industry payments across FL — which companies pay providers there.
